Marcel Leist

David Pamies, Jason Ekert, Marie-Gabrielle Zurich, et al. Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility. Stem Cell Reports. 2024;19(5):604-617. doi:10.1016/j.stemcr.2024.03.009

Sebastian Schmeisser, Andrea Miccoli, Martin von Bergen, et al. New approach methodologies in human regulatory toxicology – Not if, but how and when!. Environment International. 2023;178:108082. doi:10.1016/j.envint.2023.108082

Costanza Rovida, Francois Busquet, Marcel Leist, Thomas Hartung. REACH out-numbered! The future of REACH and animal numbers. ALTEX - Alternatives to Animal Experimentation. 2023;40(3):367-388. doi:10.14573/altex.2307121

David Pamies, Marcel Leist, Sandra Coecke, et al. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0). Alternatives to Animal Experimentation. 2022;39(1):30-70. doi:10.14573/altex.2111011

Uwe Marx, Takafumi Akabane, Tommy B. Andersson, et al. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. ALTEX. 2020;37(3):365-394. doi:10.14573/altex.2001241

Thomas Hartung, Rob De Vries, Sebastian Hoffmann, et al. Toward Good In Vitro Reporting Standards. Alternatives to Animal Experimentation. 2019;36(1):3-17. doi:10.14573/altex.1812191

Lucy Meigs, Lena Smirnova, Costanza Rovida, Marcel Leist, Thomas Hartung. Animal testing and its alternatives - the most important omics is economics. Alternatives to Animal Experimentation. 2018;35(3):275-305. doi:10.14573/altex.1807041

David Pamies, Anna Bal-Price, Christophe Chesné, et al. Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. Alternatives to Animal Experimentation. 2018;35(3):353-378. doi:10.14573/altex.1710081